Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $157.7B | $241.4B | $210.1B | $189.3B | $189.8B | |
| Revenue Growth (YoY) | 48.89% | 53.03% | -12.95% | -9.93% | 0.27% | |
| Cost of Revenues | $135.7B | $187.2B | $163.5B | $160.5B | $156.7B | |
| Gross Profit | $22.1B | $54.2B | $46.6B | $28.7B | $33B | |
| Gross Profit Margin | 13.99% | 22.44% | 22.18% | 15.17% | 17.41% | |
| R&D Expenses | $266M | $274M | $298M | $301.1M | -- | |
| Selling, General & Admin | $11.9B | $13.4B | $16.8B | $16.4B | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $11.4B | $13B | $16.6B | $13.8B | $17.5B | |
| Operating Income | $10.7B | $41.2B | $30B | $14.9B | $15.5B | |
| Net Interest Expenses | $2B | $1.9B | $2.9B | $3.7B | $5.1B | |
| EBT. Incl. Unusual Items | $11.2B | $12.9B | $22.9B | $4.8B | $7.1B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $6.7B | $16.8B | $7.9B | $5.6B | $6.5B | |
| Net Income to Company | $15.2B | $15.4B | $23.7B | $6.8B | $7.8B | |
| Minority Interest in Earnings | $922M | $1.1B | $641M | $848.4M | $1.2B | |
| Net Income to Common Excl Extra Items | $8.5B | -$1.4B | $15.9B | $1.2B | $1.3B | |
| Basic EPS (Cont. Ops) | $2.25 | -$0.79 | $5.27 | $0.14 | $0.02 | |
| Diluted EPS (Cont. Ops) | $2.24 | -$0.79 | $5.15 | $0.14 | $0.02 | |
| Weighted Average Basic Share | $3.4B | $3.2B | $2.9B | $2.7B | $2.6B | |
| Weighted Average Diluted Share | $3.4B | $3.2B | $3B | $2.8B | $2.7B | |
| EBITDA | $25.9B | $55.8B | $46.4B | $32.1B | $33.4B | |
| EBIT | $10.7B | $41.2B | $30B | $14.9B | $15.5B | |
| Revenue (Reported) | $157.7B | $241.4B | $210.1B | $189.3B | $189.8B | |
| Operating Income (Reported) | $10.7B | $41.2B | $30B | $14.9B | $15.5B | |
| Operating Income (Adjusted) | $10.7B | $41.2B | $30B | $14.9B | $15.5B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $50.6B | $69.3B | $52.1B | $45.3B | $47.3B | |
| Revenue Growth (YoY) | 91.45% | 37% | -24.71% | -13.07% | 4.38% | |
| Cost of Revenues | $42.9B | $45.4B | $41.8B | $39.8B | $39.8B | |
| Gross Profit | $7.7B | $23.9B | $10.3B | $5.6B | $7.6B | |
| Gross Profit Margin | 15.23% | 34.52% | 19.8% | 12.27% | 15.99% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $3.4B | $3.7B | $4.7B | $4.1B | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $3.3B | $3.3B | $4.7B | $3B | $4.6B | |
| Operating Income | $4.4B | $20.6B | $5.6B | $2.6B | $3B | |
| Net Interest Expenses | $759M | $834M | $1B | $1.3B | $1.3B | |
| EBT. Incl. Unusual Items | $2.9B | $16.6B | $1.2B | -$818M | -$697M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.5B | $5.7B | $663M | $1.1B | $1.6B | |
| Net Income to Company | $4B | $16.9B | $1.1B | -$503M | -$1.5B | |
| Minority Interest in Earnings | $252M | $358M | $65M | $335.9M | $296.6M | |
| Net Income to Common Excl Extra Items | $2.6B | $11.2B | $436M | -$1.6B | -$3.1B | |
| Basic EPS (Cont. Ops) | $0.70 | $3.57 | $0.13 | -$0.73 | -$1.33 | |
| Diluted EPS (Cont. Ops) | $0.70 | $3.50 | $0.13 | -$0.73 | -$1.33 | |
| Weighted Average Basic Share | $3.3B | $3B | $2.8B | $2.6B | $2.6B | |
| Weighted Average Diluted Share | $3.3B | $3.1B | $2.9B | $2.6B | $2.6B | |
| EBITDA | $8.3B | $24.3B | $9.7B | $6.8B | $7.5B | |
| EBIT | $4.4B | $20.6B | $5.6B | $2.6B | $3B | |
| Revenue (Reported) | $50.6B | $69.3B | $52.1B | $45.3B | $47.3B | |
| Operating Income (Reported) | $4.4B | $20.6B | $5.6B | $2.6B | $3B | |
| Operating Income (Adjusted) | $4.4B | $20.6B | $5.6B | $2.6B | $3B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $157.7B | $241.4B | $210.1B | $188.8B | $189.5B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $135.3B | $186.9B | $163.1B | $159.5B | $156.5B | |
| Gross Profit | $22.4B | $54.5B | $47.1B | $29.2B | $33B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $11.9B | $13.4B | $16.8B | $16.4B | $12.9B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $11.7B | $13.1B | $16.7B | $14.3B | $16.6B | |
| Operating Income | $10.7B | $41.4B | $30.4B | $14.9B | $16.4B | |
| Net Interest Expenses | $2.9B | $2.7B | $3.8B | $4.7B | $5.1B | |
| EBT. Incl. Unusual Items | $11.2B | $12.9B | $22.9B | $4.8B | $7.1B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $6.7B | $16.8B | $7.9B | $5.5B | $6.4B | |
| Net Income to Company | $15.2B | $15.4B | $23.7B | $6.8B | $7.8B | |
| Minority Interest in Earnings | $922M | $1.1B | $641M | $844.9M | $1.2B | |
| Net Income to Common Excl Extra Items | $8.5B | -$1.4B | $15.9B | $1.2B | $1.3B | |
| Basic EPS (Cont. Ops) | $2.25 | -$0.52 | $5.20 | $0.11 | $0.01 | |
| Diluted EPS (Cont. Ops) | $2.23 | -$0.62 | $5.09 | $0.09 | -$0.01 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $25.5B | $55.7B | $46.3B | $31.5B | $34.2B | |
| EBIT | $10.7B | $41.4B | $30.4B | $14.9B | $16.4B | |
| Revenue (Reported) | $157.7B | $241.4B | $210.1B | $188.8B | $189.5B | |
| Operating Income (Reported) | $10.7B | $41.4B | $30.4B | $14.9B | $16.4B | |
| Operating Income (Adjusted) | $10.7B | $41.4B | $30.4B | $14.9B | $16.4B | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $241.4B | $210.1B | $188.8B | $189.5B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $186.9B | $163.1B | $159.5B | $156.5B | -- | |
| Gross Profit | $54.5B | $47.1B | $29.2B | $33B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $13.4B | $16.8B | $16.4B | $12.9B | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $13.1B | $16.7B | $14.3B | $16.6B | -- | |
| Operating Income | $41.4B | $30.4B | $14.9B | $16.4B | -- | |
| Net Interest Expenses | $2.7B | $3.8B | $4.7B | $5.1B | -- | |
| EBT. Incl. Unusual Items | $12.9B | $22.9B | $4.8B | $7.1B | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $16.8B | $7.9B | $5.5B | $6.4B | -- | |
| Net Income to Company | $15.4B | $23.7B | $6.8B | $7.8B | -- | |
| Minority Interest in Earnings | $1.1B | $641M | $844.9M | $1.2B | -- | |
| Net Income to Common Excl Extra Items | -$1.4B | $15.9B | $1.2B | $1.3B | -- | |
| Basic EPS (Cont. Ops) | -$0.52 | $5.20 | $0.11 | $0.01 | -- | |
| Diluted EPS (Cont. Ops) | -$0.62 | $5.09 | $0.09 | -$0.01 | -- | |
| Weighted Average Basic Share | $12.7B | $11.6B | $10.9B | $10.4B | -- | |
| Weighted Average Diluted Share | $12.8B | $11.8B | $11.1B | $10.5B | -- | |
| EBITDA | $55.7B | $46.3B | $31.5B | $34.2B | -- | |
| EBIT | $41.4B | $30.4B | $14.9B | $16.4B | -- | |
| Revenue (Reported) | $241.4B | $210.1B | $188.8B | $189.5B | -- | |
| Operating Income (Reported) | $41.4B | $30.4B | $14.9B | $16.4B | -- | |
| Operating Income (Adjusted) | $41.4B | $30.4B | $14.9B | $16.4B | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $31B | $29.8B | $33.9B | $39.4B | $36.7B | |
| Short Term Investments | $280M | $578M | $843M | $165M | -- | |
| Accounts Receivable, Net | $22.3B | $28.2B | $25.2B | $21.7B | $26B | |
| Inventory | $23.7B | $28.1B | $22.8B | $23.2B | $22.5B | |
| Prepaid Expenses | $2.5B | $2.1B | $2.5B | $2.6B | $3.4B | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $92.6B | $107.7B | $104.1B | $102.8B | $101.8B | |
| Property Plant And Equipment | $112.9B | $106B | $104.7B | $100.2B | $98.6B | |
| Long-Term Investments | $44.1B | $38.5B | $36.1B | $41.2B | $46.9B | |
| Goodwill | $12.4B | $12B | $12.5B | $14.9B | -- | |
| Other Intangibles | $2.2B | $6B | $5.7B | $5.2B | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $287.3B | $288.1B | $280.3B | $282.2B | $278.5B | |
| Accounts Payable | $37.3B | $47.2B | $42.4B | $38.6B | $56.8B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $1.7B | $2.1B | $2.7B | $2.7B | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $80.3B | $99B | $86.1B | $82.2B | $80.6B | |
| Long-Term Debt | $62.5B | $50.2B | $57.1B | $64.4B | $66.3B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $196.8B | $205.1B | $194.8B | $203.9B | $204.5B | |
| Common Stock | $5.2B | $4.8B | $4.5B | $4.2B | -- | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $75.3B | $67.5B | $70.3B | $59.2B | $53.1B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $15B | $15.4B | $15.2B | $19.1B | $20.9B | |
| Total Equity | $90.4B | $83B | $85.5B | $78.3B | $74B | |
| Total Liabilities and Equity | $287.3B | $288.1B | $280.3B | $282.2B | $278.5B | |
| Cash and Short Terms | $31B | $29.8B | $33.9B | $39.4B | $36.7B | |
| Total Debt | $64.2B | $52.3B | $59.8B | $67.1B | $69.2B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $31B | $29.8B | $33.9B | $39.4B | $36.7B | |
| Short Term Investments | $280M | $578M | -- | -- | -- | |
| Accounts Receivable, Net | $22.3B | $28.2B | $25.2B | $21.7B | $26B | |
| Inventory | $23.7B | $28.1B | $22.8B | $23.2B | $22.5B | |
| Prepaid Expenses | $2.5B | $2.1B | $2.5B | $2.6B | $3.4B | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $92.6B | $107.7B | $104.1B | $102.8B | $101.8B | |
| Property Plant And Equipment | $112.9B | $106B | $104.7B | $100.2B | $98.6B | |
| Long-Term Investments | $44.1B | $38.5B | $36.1B | $41.2B | $46.9B | |
| Goodwill | $12.4B | $12B | -- | -- | -- | |
| Other Intangibles | $2.2B | $6B | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $287.3B | $288.1B | $280.3B | $282.2B | $278.5B | |
| Accounts Payable | $52.6B | $64B | $61.2B | $58.4B | $56.8B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $1.7B | $2.1B | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $80.3B | $99B | $86.1B | $82.2B | $80.6B | |
| Long-Term Debt | $62.5B | $50.2B | $57.1B | $64.4B | $66.3B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $196.8B | $205.1B | $194.8B | $203.9B | $204.5B | |
| Common Stock | $5.2B | $4.8B | $4.5B | $4.2B | -- | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $15B | $15.4B | $15.2B | $19.1B | $20.9B | |
| Total Equity | $90.4B | $83B | $85.5B | $78.3B | $74B | |
| Total Liabilities and Equity | $287.3B | $288.1B | $280.3B | $282.2B | $278.5B | |
| Cash and Short Terms | $31B | $29.8B | $33.9B | $39.4B | $36.7B | |
| Total Debt | $64.2B | $52.3B | $59.8B | $67.1B | $69.2B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $15.2B | $15.4B | $23.7B | $6.8B | $7.8B | |
| Depreciation & Amoritzation | $14.8B | $14.3B | $15.9B | $16.6B | $17.9B | |
| Stock-Based Compensation | $627M | $795M | $616M | $1.2B | $1.1B | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -$7.5B | -$5.5B | $5.6B | $808.3M | -- | |
| Cash From Operations | $23.6B | $40.9B | $32B | $27.3B | $24.6B | |
| Capital Expenditures | $10.9B | $12.1B | $14.3B | $15.3B | $13.3B | |
| Cash Acquisitions | $746M | $3.5B | $986M | -$32M | $939.2M | |
| Cash From Investing | -$5.6B | -$13.7B | -$14.5B | -$11.9B | -$9.1B | |
| Dividends Paid (Ex Special Dividend) | $4.3B | $4.4B | $4.8B | $5B | $5.1B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $7B | $2B | $7.6B | $10.7B | -- | |
| Long-Term Debt Repaid | -$16.8B | -$11.7B | -$3.9B | -$3B | -- | |
| Repurchase of Common Stock | $3.7B | $10.7B | $8.9B | $9.5B | $4.5B | |
| Other Financing Activities | $509M | -$336M | -$474M | $3.3B | -- | |
| Cash From Financing | -$18.2B | -$28B | -$13.7B | -$8.6B | -$18.4B | |
| Beginning Cash (CF) | $30.7B | $29.2B | $33B | $39.2B | $36.6B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$430M | -$1.5B | $3.8B | $6.2B | -$2.7B | |
| Ending Cash (CF) | $30B | $27B | $36.9B | $44.9B | $34.2B | |
| Levered Free Cash Flow | $12.7B | $28.9B | $17.8B | $12B | $11.3B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $4B | $16.9B | $1.1B | -$503M | -$1.5B | |
| Depreciation & Amoritzation | $3.7B | $3.4B | $4.1B | $4.3B | $4.5B | |
| Stock-Based Compensation | $226M | $166M | $97M | $228M | $196.3M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -$8.5B | -$6.1B | $10.9B | -$415M | -- | |
| Cash From Operations | $6.1B | $13.6B | $9.4B | $7.4B | $7.6B | |
| Capital Expenditures | $2.8B | $3.7B | $4.2B | $3.9B | $3.5B | |
| Cash Acquisitions | $132M | $3.5B | $45M | -$472M | $643.1M | |
| Cash From Investing | -$1.3B | -$6.7B | -$4.4B | -$940M | -$492.4M | |
| Dividends Paid (Ex Special Dividend) | $1.1B | $1.1B | $1.2B | $1.3B | $1.3B | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $648M | $10M | $1.5B | $3.3B | -- | |
| Long-Term Debt Repaid | -$3B | -$2.2B | -$11M | -$717M | -- | |
| Repurchase of Common Stock | $2.3B | $3.9B | $2.4B | $2.7B | -$381M | |
| Other Financing Activities | -$23M | -$171M | -$248M | $3.6B | -- | |
| Cash From Financing | -$4.8B | -$7.1B | -$2B | -$1.4B | -$5.4B | |
| Beginning Cash (CF) | $30.7B | $29.2B | $33B | $39.2B | $36.6B | |
| Foreign Exchange Rate Adjustment | -$58M | $177M | $145M | -$419M | -$2.3M | |
| Additions / Reductions | -$13M | -$109M | $3.1B | $4.7B | $1.7B | |
| Ending Cash (CF) | $30.6B | $29.3B | $36.3B | $43.5B | $38.2B | |
| Levered Free Cash Flow | $3.3B | $9.9B | $5.1B | $3.5B | $4.1B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $15.2B | $15.4B | $23.7B | $6.8B | $7.8B | |
| Depreciation & Amoritzation | $14.8B | $14.3B | $15.9B | $16.6B | $17.9B | |
| Stock-Based Compensation | $627M | $795M | $616M | $1.2B | $1.1B | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -$7.5B | -$5.5B | $5.6B | $808M | -- | |
| Cash From Operations | $23.6B | $40.9B | $32B | $27.3B | $24.6B | |
| Capital Expenditures | $10.9B | $12.1B | $14.3B | $15.3B | $13.3B | |
| Cash Acquisitions | $746M | $3.5B | $986M | -$32M | $939.2M | |
| Cash From Investing | -$5.6B | -$13.7B | -$14.5B | -$11.9B | -$9.1B | |
| Dividends Paid (Ex Special Dividend) | $4.3B | $4.4B | $4.8B | $5B | $5.1B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $7B | $2B | $7.6B | $10.7B | -- | |
| Long-Term Debt Repaid | -$16.8B | -$11.7B | -$3.9B | -$3B | -- | |
| Repurchase of Common Stock | $3.7B | $10.7B | $8.9B | $9.5B | $4.5B | |
| Other Financing Activities | $509M | -$336M | -$474M | $3.3B | -- | |
| Cash From Financing | -$18.2B | -$28B | -$13.7B | -$8.6B | -$18.4B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$430M | -$1.5B | $3.8B | $6.2B | -$2.7B | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $12.7B | $28.9B | $17.8B | $12B | $11.3B | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $15.4B | $23.7B | $6.8B | $7.8B | -- | |
| Depreciation & Amoritzation | $14.3B | $15.9B | $16.6B | $17.9B | -- | |
| Stock-Based Compensation | $795M | $616M | $1.2B | $1.1B | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -$5.5B | $5.6B | $808M | -- | -- | |
| Cash From Operations | $40.9B | $32B | $27.3B | $24.6B | -- | |
| Capital Expenditures | $12.1B | $14.3B | $15.3B | $13.3B | -- | |
| Cash Acquisitions | $3.5B | $986M | -$32M | $939.2M | -- | |
| Cash From Investing | -$13.7B | -$14.5B | -$11.9B | -$9.1B | -- | |
| Dividends Paid (Ex Special Dividend) | $4.4B | $4.8B | $5B | $5.1B | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $2B | $7.6B | $10.7B | $1.2B | -- | |
| Long-Term Debt Repaid | -$11.7B | -$3.9B | -$3B | -$2.2B | -- | |
| Repurchase of Common Stock | $10.7B | $8.9B | $9.5B | $4.5B | -- | |
| Other Financing Activities | -$336M | -$474M | $3.3B | $861M | -- | |
| Cash From Financing | -$28B | -$13.7B | -$8.6B | -$18.4B | -- | |
| Beginning Cash (CF) | $126B | $122.3B | $140.2B | $140.3B | -- | |
| Foreign Exchange Rate Adjustment | -$684M | $27M | -$511M | $246.6M | -- | |
| Additions / Reductions | -$1.5B | $3.8B | $6.2B | -$2.7B | -- | |
| Ending Cash (CF) | $123.9B | $126.2B | $145.9B | $137.9B | -- | |
| Levered Free Cash Flow | $28.9B | $17.8B | $12B | $11.3B | -- | |
Signup to receive the latest stock alerts
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Though certainly less well-known than the huge tech businesses that…
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Market Cap: $4.6T
P/E Ratio: 65x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 29x
Teradata Corp. [TDC] is down 11.64% over the past day.
Diodes, Inc. [DIOD] is down 7.63% over the past day.
Vertiv Holdings Co. [VRT] is down 4.79% over the past day.